Veröffentlichungen zu Hammes, Hans-Peter von Brownlee, Michael[x] | ||||||||||||||
Verfasser | Titel | Jahr ![]() ![]() |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() 1 |
Hammes, Hans-Peter, Brownlee, Michael, ... |
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization in: Nature medicine . - New York, NY : Nature America Inc., ISSN 1546-170X, Vol. 2, No. 5 (1996), p. 529-533 Zugang: zum Volltext ähnliche Vorschläge |
1996 | |||||||||||
Retinal neovascularization is a major cause of blindness in such disorders as retinopathy of prematurity, proliferative diabetic retinopathy and senile macular degeneration. Because ligation of vitronectin receptor–type integrins appears to be required for the survival and maturation of newly... mehr
|
||||||||||||||
![]() 2 |
Nishikawa, Takeshi, Edelstein, Diane, ... |
Normalizing mitochondrial superoxide production blocks three pathwaysof hyperglycaemic damage in: Nature . - London [u.a.] : Nature Publising Group, ISSN 1476-4687, Vol. 404, No. 6779 (2000), p. 787-790 Zugang: zum Volltext ähnliche Vorschläge |
2000 | |||||||||||
![]() 3 |
Hammes, Hans-Peter, Du, Xueliang, ... |
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy in: Nature medicine . - New York, NY : Nature America Inc., ISSN 1546-170X, Vol. 9, No. 3 (2003), p. 294-299 Zugang: zum Volltext ähnliche Vorschläge |
2003 |